D
David E. Cohn
Researcher at Ohio State University
Publications - 350
Citations - 16599
David E. Cohn is an academic researcher from Ohio State University. The author has contributed to research in topics: Endometrial cancer & Gynecologic oncology. The author has an hindex of 60, co-authored 350 publications receiving 13703 citations. Previous affiliations of David E. Cohn include University of Alabama at Birmingham & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly Resnick,Hansjuerg Alder,John P. Hagan,Debra L. Richardson,Carlo M. Croce,David E. Cohn +5 more
TL;DR: It is demonstrated that the extraction of RNA and subsequent identification of miRNAs from the serum of individuals diagnosed with ovarian cancer is feasible and real-time PCR-based microarray is a novel and practical means to performing high-throughput investigation of serum RNA samples.
Journal ArticleDOI
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Wui Jin Koh,Nadeem R. Abu-Rustum,Sarah M. Bean,Kristin A. Bradley,Susana M. Campos,Kathleen R. Cho,Hye Sook Chon,Christina Chu,Rachel M. Clark,David E. Cohn,Marta A. Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Ernest S. Han,Warner K. Huh,John R. Lurain,Andrea Mariani,David G. Mutch,Christa Nagel,Larissa Nekhlyudov,Amanda N. Fader,Steven W. Remmenga,R. Kevin Reynolds,Todd Tillmanns,Stefanie Ueda,Emily Wyse,Catheryn M. Yashar,Nicole R. McMillian,Jillian L. Scavone +32 more
TL;DR: This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations.
Journal ArticleDOI
Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients
Heather Hampel,Wendy L. Frankel,Jenny Panescu,Janet Lockman,Kaisa Sotamaa,Daniel Fix,Ilene Comeras,Jennifer La Jeunesse,Hidewaki Nakagawa,Judith A. Westman,Thomas W. Prior,Mark Clendenning,Pamela Penzone,Janet Lombardi,Patti Dunn,David E. Cohn,Larry J. Copeland,Lynne A. Eaton,Jeffrey M. Fowler,George S. Lewandowski,Luis Vaccarello,Jeffrey A. Bell,Gary C. Reid,Albert de la Chapelle +23 more
TL;DR: It is concluded that in central Ohio, at least 1.8% (95% confidence interval, 0.9-3.5%) of newly diagnosed endometrial cancer patients had Lynch syndrome, and a combination of MSI and immunohistochemical staining followed by gene sequencing and deletion analysis is feasible and may be desirable.
Journal ArticleDOI
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Bradley J. Monk,Michael W. Sill,D. Scott McMeekin,David E. Cohn,Lois M. Ramondetta,Cecelia H. Boardman,Jo Ann Benda,David Cella +7 more
TL;DR: VC, GC, and TC are not superior to PC in terms of overall survival (OS), however, the trend in RR, PFS, and OS favors PC.
Journal ArticleDOI
Uterine Neoplasms, Version 1.2018: Clinical practice guidelines in oncology
Wui Jin Koh,Nadeem R. Abu-Rustum,Sarah M. Bean,Kristin A. Bradley,Susana M. Campos,Kathleen R. Cho,Hye Sook Chon,Christina Chu,David E. Cohn,Marta A. Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Suzanne George,Ernest S. Han,Susan Higgins,Warner K. Huh,John R. Lurain,Andrea Mariani,David Mutch,Christa Nagel,Larissa Nekhlyudov,Amanda Nickles Fader,Steven W. Remmenga,R. Kevin Reynolds,Todd Tillmanns,Stefanie Ueda,Emily Wyse,Catheryn M. Yashar,Nicole R. McMillian,Jillian L. Scavone +33 more
TL;DR: Guiding principles for the diagnosis, staging, and treatment of early-stage endometrial carcinoma are discussed as well as evidence for these recommendations.